Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling pathways in the skin wound microenvironment represent the complex network of local intercellular communication required for successful tissue regeneration. This system involves the secretion of diverse signaling molecules, including growth factors (e.g., PDGF, TGF-beta, VEGF) and cytokines, by resident and recruited cells such as macrophages, fibroblasts, and keratinocytes (Werner & Grose, 2003, Physiological Reviews). These factors act on neighboring cells to coordinate the overlapping phases of inflammation, proliferation, and remodeling (Gurtner et al., 2008, Nature). Dysregulation of these pathways is a hallmark of chronic, non-healing wounds like diabetic foot ulcers, where a pro-inflammatory environment persists, or in pathological scarring where signaling remains overactive (Pastar et al., 2014, Advances in Wound Care). While not a single molecular target, this microenvironment contains numerous druggable components; for instance, Becaplermin is a recombinant PDGF that mimics endogenous paracrine signals to promote healing (Eming et al., 2014, Sci Transl Med). Therapeutic strategies often aim to restore the spatiotemporal balance of these signals to accelerate closure while minimizing the risk of fibrosis.
Modulation of growth factor receptors and cytokine signaling cascades to restore the physiological balance of the wound microenvironment and promote tissue repair (Werner & Grose, 2003).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling pathways in skin wound microenvironment.